Palo Alto, CA
GondolaBio is a clinical-stage biopharmaceutical company focused on developing breakthrough therapeutics for genetic diseases. GondolaBio is an independent sister company to BridgeBio, originally carved out in 2024 after securing $300M in private financing from external investors. GondolaBio aims to leverage cutting‑edge biological research to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases.
Patient Days, whereby we are fortunate to hear directly from individuals living with the conditions we are seeking to impact throughout the year and learn how we can improve our efforts.
A culture inspired by our values: put patients first, think independently, be radically transparent, every minute counts, and let the science speak.
An unyielding commitment to always putting patients first.
A decentralized model that enables our program teams to focus on advancing science and helping patients.
A place where you own the vision – both for your program and your own career path.
A collaborative, fast‑paced, data‑driven environment where we inspire ourselves and each other to always perform at the top of our game.
Access to learning and development resources to support career growth.
Flexible PTO.
Rapid career advancement for strong performers.
Commitment to Diversity, Equity & Inclusion.
The base pay range for this position is $185,000 to $215,000 per year. The actual compensation offered will be determined based on a number of job‑related factors, including experience, skills, qualifications, and location. A bonus plan and equity will also be offered.
#J-18808-Ljbffr
